Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 21, 2017 - Issue 6
Submit an article Journal homepage
634
Views
24
CrossRef citations to date
0
Altmetric
Review

Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery

Satheeshkumar SellamuthuPharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi, IndiaView further author information
,
Meenakshi SinghPharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi, IndiaView further author information
,
Ashok KumarPharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi, IndiaView further author information
&
Sushil Kumar SinghPharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi, IndiaCorrespondence[email protected]
View further author information
Pages 559-570 | Received 22 Aug 2016, Accepted 03 May 2017, Published online: 15 May 2017

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yuanyuan Li, Lei Fu, Weiyan Zhang, Xi Chen & Yu Lu. (2021) The Transcription Factor Rv1453 Regulates the Expression of qor and Confers Resistant to Clofazimine in Mycobacterium tuberculosis. Infection and Drug Resistance 14, pages 3937-3948.
Read now

Articles from other publishers (23)

Qian Yu, Qiongna Cai, Wanxin Liang, Kewen Zhong, Jiayong Liu, Haizhou Li, Yongzhi Chen, Hongxia Li, Shanfang Fang, Rongcui Zhong, Shouping Liu & Shuimu Lin. (2023) Design of phenothiazine-based cationic amphiphilic derivatives incorporating arginine residues: Potential membrane-active broad-spectrum antimicrobials combating pathogenic bacteria in vitro and in vivo. European Journal of Medicinal Chemistry 260, pages 115733.
Crossref
Nikita Goel, Stuti Srivastav, Arjun Patel, Akshay Shirsath, Tushar Ranjan Panda, Malay Patra, Adam M. Feist & Amitesh Anand. (2023) TCA cycle tailoring facilitates optimal growth of proton-pumping NADH dehydrogenase-dependent Escherichia coli . Microbiology Spectrum.
Crossref
Lakshmi Mounika Kelam, Mushtaq Ahmad Wani & Devendra K. Dhaked. (2023) An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis. Progress in Biophysics and Molecular Biology 180-181, pages 87-104.
Crossref
Sheng Wang, Bing Wang, Xinxin You & Linna Du. (2023) Transcriptomic responses of the fast-growing bacterium Vibrio natriegens during cold-induced loss of culturability. Applied Microbiology and Biotechnology 107:9, pages 3009-3019.
Crossref
Ankit Ganeshpurkar, Ravi Singh, Meenakshi Singh, Ashok Kumar & Sushil Kumar Singh. 2023. Tuberculosis. Tuberculosis 541 569 .
Pragya Anand & Yusuf Akhter. (2022) A review on enzyme complexes of electron transport chain from Mycobacterium tuberculosis as promising drug targets. International Journal of Biological Macromolecules 212, pages 474-494.
Crossref
Summaya Perveen & Rashmi Sharma. (2022) Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery. Biochemical Pharmacology 197, pages 114906.
Crossref
Lloyd Tanner, Gabriel T. Mashabela, Charles C. Omollo, Timothy J. de Wet, Christopher J. Parkinson, Digby F. Warner, Richard K. Haynes & Lubbe Wiesner. (2021) Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy. Microbiology Spectrum 9:2.
Crossref
Margarida DuarteCleide FerreiraGurleen Kaur Khandpur, Tamara Flohr, Jannik ZimmermannHelena CastroJohannes M. Herrmann, Bruce MorganAna M. Tomás. (2021) Leishmania type II dehydrogenase is essential for parasite viability irrespective of the presence of an active complex I . Proceedings of the National Academy of Sciences 118:42.
Crossref
Yiqing Yang, Tongke Tang, Xiaolu Li, Thomas Michel, Liqin Ling, Zhenghui Huang, Maruthi Mulaka, Yue Wu, Hongying Gao, Liguo Wang, Jing Zhou, Brigitte Meunier, Hangjun Ke, Lubin Jiang & Yu Rao. (2021) Design, synthesis, and biological evaluation of multiple targeting antimalarials. Acta Pharmaceutica Sinica B 11:9, pages 2900-2913.
Crossref
Yu Cao, Chen Sun, Han Wen, Mengfei Wang, Pan Zhu, Mengjiao Zhong, Jian Li, Xuewei Chen, Yefeng Tang, Jingwen Wang & Bing Zhou. (2021) A Yeast-Based Drug Discovery Platform To Identify Plasmodium falciparum Type II NADH Dehydrogenase Inhibitors. Antimicrobial Agents and Chemotherapy 65:6.
Crossref
Karan Gandhi & Mehul Patel. (2021) Collocating Novel Targets for Tuberculosis (TB) Drug Discovery. Current Drug Discovery Technologies 18:2, pages 307-316.
Crossref
Milan Urban, Veronika Šlachtová & Lucie Brulíková. (2021) Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 212, pages 113139.
Crossref
Maria Giulia Nizi, Jenny Desantis, Yoshio Nakatani, Serena Massari, Maria Angela Mazzarella, Gauri Shetye, Stefano Sabatini, Maria Letizia Barreca, Giuseppe Manfroni, Tommaso Felicetti, Rowena Rushton-Green, Kiel Hards, Gniewomir Latacz, Grzegorz Satała, Andrzej J. Bojarski, Violetta Cecchetti, Michal H. Kolář, Jadwiga Handzlik, Gregory M. Cook, Scott G. Franzblau & Oriana Tabarrini. (2020) Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors. European Journal of Medicinal Chemistry 201, pages 112420.
Crossref
Qian Li & Xiaoyun Lu. (2020) New antituberculosis drugs targeting the respiratory chain. Chinese Chemical Letters 31:6, pages 1357-1365.
Crossref
Marie-Joelle Virolle. (2020) A Challenging View: Antibiotics Play a Role in the Regulation of the Energetic Metabolism of the Producing Bacteria. Antibiotics 9:2, pages 83.
Crossref
Gopichand Gutti, Karan Arya & Sushil Kumar Singh. (2019) Latent Tuberculosis Infection (LTBI) and Its Potential Targets: An Investigation into Dormant Phase Pathogens. Mini-Reviews in Medicinal Chemistry 19:19, pages 1627-1642.
Crossref
Lucia Trisolini, Nicola Gambacorta, Ruggiero Gorgoglione, Michele Montaruli, Luna Laera, Francesco Colella, Mariateresa Volpicella, Anna De Grassi & Ciro Leonardo Pierri. (2019) FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function. Journal of Clinical Medicine 8:12, pages 2117.
Crossref
Hangjun Ke, Suresh M. Ganesan, Swati Dass, Joanne M. Morrisey, Sovitj Pou, Aaron Nilsen, Michael K. Riscoe, Michael W. Mather & Akhil B. Vaidya. (2019) Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages. PLOS ONE 14:4, pages e0214023.
Crossref
Satheeshkumar Sellamuthu, Mohammad F. Bhat, Ashok Kumar, Gopal Nath & Sushil K. Singh. (2019) Design, Synthesis and Biological Evaluation of Carbazole Derivatives as Antitubercular and Antibacterial Agents. Current Bioactive Compounds 15:1, pages 83-97.
Crossref
Abed Tarapdar, James K S Norris, Oliver Sampson, Galina Mukamolova & James T Hodgkinson. (2018) The design and synthesis of an antibacterial phenothiazine–siderophore conjugate. Beilstein Journal of Organic Chemistry 14, pages 2646-2650.
Crossref
Chin-Hsiao Tseng. (2018) Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients. Journal of Clinical Medicine 7:9, pages 264.
Crossref
Filipa V. Sena, Filipe M. Sousa, A. Sofia F. Oliveira, Cláudio M. Soares, Teresa Catarino & Manuela M. Pereira. (2018) Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus. Redox Biology 16, pages 209-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.